Valuation: SSY Group Limited

Market Cap 7.46B 951M 852M 783M 710M 1.33B 90.29B 1.35B 9.34B 3.75B 47.49B 3.57B 3.49B 150B P/E 2026 *
12.9x
P/E 2027 * 11.2x
Enterprise Value 7.46B 951M 852M 783M 710M 1.33B 90.29B 1.35B 9.34B 3.75B 47.49B 3.57B 3.49B 150B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.44x
Free-Float
32.68%
Yield 2026 *
4.26%
Yield 2027 * 5.04%
1 day+0.19%
1 week+0.39%
1 month-8.67%
3 months+8.40%
6 months+12.17%
Current year-8.83%
1 week 2.53
Extreme 2.53
2.64
1 month 2.53
Extreme 2.53
2.84
Current year 2.01
Extreme 2.01
3.15
1 year 2.01
Extreme 2.01
3.18
3 years 2.01
Extreme 2.01
5.2
5 years 2.01
Extreme 2.01
5.68
10 years 2.01
Extreme 2.01
9.46
Manager TitleAgeSince
Chief Executive Officer 69 23/03/2010
Director of Finance/CFO 45 01/04/2015
Corporate Officer/Principal 42 28/08/2024
Director TitleAgeSince
Chairman 69 04/06/2014
Director/Board Member 61 26/07/2007
Director/Board Member 57 16/10/2005
Date Insider Type Main position Quantity % Market Cap. Importance
2/10/26 Other

Chief Executive Officer

500,000 0.0169%
29/9/26 Other

Chief Executive Officer

1,500,000 0.0508%
25/9/26 Other

Chief Executive Officer

500,000 0.0169%
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%+0.39%-16.77%-39.86% 951M
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.90%+5.35%+40.25%+72.12% 426.29B
Weighted average by Cap. +2.01%+6.60%+50.49%+100.40%

Financials

2026 *2027 *
Net sales 4.71B 600M 538M 494M 448M 837M 56.99B 853M 5.9B 2.37B 29.98B 2.25B 2.2B 94.54B 5.18B 660M 591M 544M 493M 921M 62.7B 939M 6.49B 2.6B 32.98B 2.48B 2.43B 104B
Net income 601M 76.67M 68.66M 63.16M 57.23M 107M 7.28B 109M 753M 302M 3.83B 288M 282M 12.08B 676M 86.22M 77.22M 71.03M 64.36M 120M 8.19B 123M 847M 340M 4.31B 324M 317M 13.58B
Net Debt - -
Projected Income Statement - Annual - SSY Group Limited
Logo SSY Group Limited
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Employees
5,400
Date Price Change Volume
30/10/26 HKD 2.580 +0.19% 5,200,000
29/10/26 HKD 2.575 -1.72% 7,150,000
28/10/26 HKD 2.620 -0.76% 1,320,000
27/10/26 HKD 2.640 +0.96% 4,354,000
26/10/26 HKD 2.615 +1.75% 1,972,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - SSY Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.580HKD
Average target price
3.925HKD
Spread / Average Target
+52.13%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - SSY Group Limited
  1. Stock Market
  2. Stocks
  3. 2005 Stock